EU approved Sanofi’s Cenrifki as first disability-taegeting medicine for SPMS
Sanofi announced that the European Commission has approved Cenrifki (tolebrutinib), marking a historic milestone as the first and only therapy authorized in the European Union specifically...
FDA Approves Utebzi for Complicated Urinary Tract Infections
GSK plc and Spero Therapeutics announced that the US Food and Drug Administration (FDA) has approved Utebzi(tebipenem pivoxil). It is indicated for adult patients with complicated urinary tract...
Lupin Introduces Azilsartan Medoxomil Tablets in the United States
Lupin Limited (Lupin) the Indian Global pharmaceuticals major announced that the company will launch Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States, which got approval from the U.S. byAbbreviated New Drug Application (ANDA).
This is a bioequivalent product of Edarbi® produces byAzurity Pharmaceuticals,...
FDA Grants Accelerated Approval to Sanofi’s Tzield® for Pediatric Stage 3 Type 1 Diabetes
The U.S. Food and Drug Administration has granted accelerated approval to Sanofi's Tzield® (teplizumab-mzwv) for children aged 8 to 17 years recently diagnosed with stage...
AstraZeneca Advances Oral GLP-1 Elecoglipron to Phase III Programme
AstraZeneca announced positive results from the VISTA and SOLSTICE Phase IIb trials of elecoglipron, an investigational oral small molecule glucagon-like peptide-1 receptor agonist (GLP-1 RA). The data,...
CDSCO Tightens Action Against Banned Antibiotics After Shrimp Export Rejections Jump 43%
The Central Drugs Standard Control Organisation (CDSCO), under India's Ministry of Health and Family Welfare, has issued a directive to all State and Union...